DYN
Dyne Therapeutics Inc

2,660
Mkt Cap
$2.64B
Volume
9.98M
52W High
$27.59
52W Low
$6.36
PE Ratio
-5.38
DYN Fundamentals
Price
$19.69
Prev Close
$18.44
Open
$19.57
50D MA
$18.74
Beta
1.77
Avg. Volume
2.58M
EPS (Annual)
-$3.37
P/B
4.06
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Why Dyne Therapeutics Stock Was a Big Winner on Wednesday
Key PointsAn analyst upgraded his recommendation on the biotech...
Nasdaq News: Markets·2h ago
News Placeholder
More News
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Sees Strong Trading Volume - Here's What Happened
Dyne Therapeutics (NASDAQ:DYN) Sees Unusually-High Trading Volume - Time to Buy...
MarketBeat·8h ago
News Placeholder
Dyne Therapeutics Prices Upsized Public Offering Of 18.98 Mln Shares
(RTTNews) - Dyne Therapeutics, Inc.(DYN) said that it has priced an upsized underwritten public offering of 18.980 million shares at $18.44 per share for the gross proceeds of $350 million. The...
Nasdaq News: Markets·21h ago
News Placeholder
Why Dyne Therapeutics Stock Tanked on Tuesday
Key PointsThe biotech announced a secondary stock issue...
Nasdaq News: Markets·1d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Down - Here's What Happened
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Down - Here's What Happened...
MarketBeat·1d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Down - Here's What Happened
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Down - Here's What Happened...
MarketBeat·1d ago
News Placeholder
HC Wainwright Has Bullish Forecast for DYN FY2029 Earnings
Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) - Equities researchers at HC Wainwright upped their FY2029 EPS estimates for shares of Dyne Therapeutics in a research note issued on Monday...
MarketBeat·2d ago
News Placeholder
Why Dyne Therapeutics Stock Was Blasting Higher Today
Key PointsIts No. 1 drug candidate did well in a clinical trial...
Nasdaq News: Markets·2d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Up Following Analyst Upgrade
Dyne Therapeutics (NASDAQ:DYN) Shares Gap Up After Analyst Upgrade...
MarketBeat·2d ago
News Placeholder
HC Wainwright Forecasts Strong Price Appreciation for Dyne Therapeutics (NASDAQ:DYN) Stock
HC Wainwright raised their price target on Dyne Therapeutics from $46.00 to $60.00 and gave the company a "buy" rating in a research report on Monday...
MarketBeat·2d ago

Latest DYN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.